Hyper Corporation Inc.

Hyper Corporation Inc.

KKRX:065650
1,829.00
KRW
-122.00
(-6.25%)
-454.36EPS
38.64BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
7,155.67
3,406.43
5,152.76
7,956.31
12,942.34
10,811.62
9,397.17
14,295.85
18,537.63
16,572.02
14,000.46
86,141.34
11,449.56
10,678.15
Basic EPS, GAAP
-1,273.07
-5,356.22
-1,071.24
-2,406.42
-7,088
-3,024
-960
-1,602.37
-2,544
-4,400
-640
-119,968.08
-47.43
-401.4
Free Cash Flow per Basic Share
-978.19
-8.08
-128.05
-727.78
-759.72
-565.4
-2,366.77
-1,379.85
-1,758.63
-1,555.27
-817.03
-14,380.24
-1,332.4
-1,150.16
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
21,068.02
15,693.11
14,974.12
14,937.64
13,451.44
10,433.1
9,614.38
11,981.31
15,513.73
10,574.38
11,408.04
2,627.18
2,307.56
2,439.62
Tangible Book Value per Share
3,747.73
2,384.25
2,612.81
5,293.98
10,975.11
10,226.02
9,328.86
4,370.68
12,066.06
10,475.84
11,289.52
1,557.89
1,431.25
1,906.36
Basic Weighted Avg Shares
2
2
2
2
2
2
2
2
3
3
3
1
7
8
Sales/Revenue/Turnover
11,326
5,407
8,215
13,097
20,910
19,890
17,413
31,415
49,251
45,290
42,885
57,699
76,187
80,768
Operating Margin (%)
-14.5
-41.44
3.08
-3.64
2.3
-7.89
-12.41
-6.89
1.75
-8.96
-4.42
-6.68
-5.62
-2.96
Depreciation Expense
127
150
34
18
16
38
52
294
826
904
898
2,815
2,294
2,398
Net Income, GAAP
-2,015
-8,502
-1,708
-3,961
-11,452
-5,563
-1,779
-3,521
-6,759
-12,025
-1,960
-80,357
-316
-3,036
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
290.02
- -
Profit Margin (%)
-17.79
-157.24
-20.79
-30.25
-54.77
-27.97
-10.22
-11.21
-13.72
-26.55
-4.57
-139.27
-0.41
-3.76
Working Capital
6,264
4,711
6,797
7,837
19,739
18,538
16,600
5,010
13,103
34,136
14,683
-11,621
-5,203
3,796
LT Debt
- -
- -
5,749
- -
- -
- -
16
695
530
4,343
861
5,112
4,334
3,974
Total Equity
33,483
24,941
23,798
25,573
24,750
19,196
17,690
27,856
42,290
31,091
36,893
17,490
15,312
25,735
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
16.95
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-26.59
- -
Return on Common Equity (%)
-5.85
-29.11
-7.01
-16.05
-45.51
-25.32
-9.65
-15.46
-19.27
-32.77
-5.77
-295.53
-1.92
-13.6

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
67,624
38,380
40,555
LT Borrowings
- -
- -
- -
LT Finance Leases
4,487
4,334
3,974
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
7
11
Market Capitalization
51,104
26,683
38,635

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
81,924
45,411
56,382
Cash, Cash Equivalents & STI
44,853
18,226
27,995
Accounts Receivable, Net
16,577
18,346
20,091
Inventories
4,130
5,537
5,434
Total Current Liabilities
80,777
50,615
52,586
Payables & Accruals
- -
- -
- -
ST Debt
67,624
38,380
40,555
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.04%
-4.21%
-12.45%
Free Cash Flow
104.57%
56.17%
-7.96%
Net Income, GAAP
428.51%
797.12%
-99.61%
Sales/Revenue/Turnover
29.22%
22%
32.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
14,558
12,450
16,577
13,063
57,699
2025
18,934
14,557
23,118
19,578
76,187
2026
23,516
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-2,411.29
-22,944
0.24
-8,573.99
-119,968.08
2025
35.87
804.67
-490.58
-433.93
-47.43
2026
-218.48
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Sang-Seok Lee
Full Time Employees
83
Sector
Distribution services
Industry
Electronics distributors
Address
Seoul South Korea
IPO Date
Jan 21, 2003
Business
Hyper Corporation Inc. is a South Korea-based technology, biopharmaceutical, and life-care platform company. Founded in 1997 and headquartered in Seoul, South Korea, the company operates across biopharmaceuticals, artificial intelligence life-care platforms, digital commerce, and IT distribution. The company's core products and services include: clinical-stage biopharmaceutical research and development focusing on Alzheimer's disease therapeutics, beta-amyloid aggregation inhibitors, RAGE modulators, and early diagnostic kits; non-narcotic neuropathic pain treatments utilizing TRPV1 antagonists and agonists; artificial intelligence-powered life-care solutions and data analytics platforms delivering personalized senior wellness and junior care services under brands such as ProMom Kinder and Blue Tiger; enterprise digital commerce and mobile coupon infrastructure, including the Gift-N and GiftLetter platforms for corporate promotional vouchers, consumer gift cards, and employee welfare benefits; and the wholesale distribution of IT hardware and computer peripherals. In recent major developments, the company officially changed its corporate name from Medifron DBT Co., Ltd. to Hyper Corporation Inc. in March 2024 to signify its strategic pivot toward AI-integrated lifecycle and healthcare platforms. As part of its portfolio restructuring, the company divested its home meal replacement food business division to concentrate capital on core technology and healthcare operations. Hyper Corporation has expanded its service ecosystem through the strategic acquisition of mobile voucher specialist GiftLetter and premium membership brands, while establishing strategic technology alliances with artificial intelligence firms such as Directors Tech to advance its proprietary data infrastructure. Furthermore, the company restructured its equity and capital framework through significant convertible bond issuances and third-party allocated capital increases, leading to a change in its largest shareholder structure and establishing an independent operational management base.